#1 Masayasu NAITO, M.D. Surgeon
・Surgical oncology and immunology
・Cancer peptide vaccine therapy
Dr Naito received his MD form Fukuoka University School of Medicine in 2000. He also received PhD from Kurume University School of Medicine in 2009. In 2010, he joined Dana-Ferber cancer institute to research cancer immunotherapy. In 2016, He headed a director in Naito Hospital. In addition, he joined cancer vaccine center in Kurume University Hospital. His profession is surgery, chemotherapy and cancer immunotherapy (cancer vaccine therapy).
#2 Shigeru HAYASHIDA, M.D. Physician
・Hyperthermia chemotherapy ・Adoptive Immunotherapy
#3 Seiichiro HOSHINO, M.D. Surgeon
・SSurgical oncology and gastroenterogy
Seiichiro Hoshino, M.D. Vice director Naito Hospital. Dr.Seiichiro Hoshino is a graduate of the Miyazaki University School of Medicine. He received his PhD degree in Fukuoka University School of Medicine in 2006. His specialty is digestive surgery and endoscopic surgery. He worked in Department of Gastroenterological Surgery, Fukuoka University School of Medicine as Associate Professor until 2014, and is now a vice director of Naito Hospital.
#4 Toru KUME, M.D. Surgeon
・Surgical oncology and gastroenterogy ・Palliative care
#5 Noriaki ITAI, M.D. Physician
・Pulmonary and respiratory medicine
#6 Masatoshi TANAKA, M.D. Physician
・Interventional oncology and hepatology
Masatoshi Tanaka, M.D. Director, Department of Hepatology and Clinical Research Center, Yokokura Hospital 394, Nose, Takada-machi, Miyama, 839-0245, Japan Dr Masatoshi Tanaka graduated Kurume university school of medicine in 1979, and received his PhD degree in Medical Science in 1989. His profession is a diagnosis and treatment of hepatocellular carcinoma (HCC). He started his carrier of percutaneous ethanol injection (PEI) from 1985, intra-arterial embolo-therapy and chemotherapy from 1989, and radiofrequency ablation from 1998. He was a director at the Dept. of Gastroenterology and Hepatology, Kurume University Medical Center, and is now a director of Hepatology and Clinical Research Center, Yokokura hospital since 2012. He is a board member of Liver Cancer Study Group of Japan, Japanese Society of Gastraenterology, Hepatology and Ultrasonics in medicine, and also a director board member of Asian Conference on Tumor Ablation, and organized 2nd ACTA meeting in 2015.
Medical corporation SHOUFUKAI NAITO HOSPITAL
1-1169, Nishimachi, Kurume, Fukuoka 830-0038,JAPAN